ID
45858
Description
Principal Investigator: Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001018 We performed comprehensive molecular profiling of renal tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of response and resistance to existing and emerging therapies in this disease, as well as mechanisms of tumor evolution in the context of treatment.
Lien
Mots-clés
Versions (1)
- 08/10/2023 08/10/2023 - Simon Heim
Détendeur de droits
Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
Téléchargé le
8 octobre 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs001018 Molecular Characterization of Clinical Renal Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
C0680251 (UMLS CUI [1,2])
C0740457 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0475358 (UMLS CUI [1,4])
C3845275 (UMLS CUI [1,5])